Bosutinib is a medication primarily used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the white blood cells. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the activity of specific proteins involved in cancer cell growth and spread. Bosutinib is specifically indicated for the treatment of adults with newly diagnosed CML or CML that has not responded to other treatments. It is typically taken orally in tablet form.
| Active Ingredient (Generic Name): | Bosutinib |
| Manufacturer: |
Glenmark Pharmaceuticals Ltd.
|
| Packaging: | 60 tablets in 1 bottle |
| Strength: | 100 mg |
| Delivery Time: | 6 To 15 days |
| SKU: | Bosutinib 100 mg |
Reviews
There are no reviews yet.